Evidence map›Paper›PMID 29233990›Full record

ArticleNature communications2017

Balancing mcr-1 expression and bacterial survival is a delicate equilibrium between essential cellular defence mechanisms.

Qiue Yang, Mei Li, Owen B Spiller, Diego O Andrey, Philip Hinchliffe, Hui Li, Craig MacLean, Pannika Niumsup, Lydia Powell, Manon Pritchard and 11 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 122 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
122citing papers in PubMed, 1 pooled it
4.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

122 citing papers in PubMed, 1 synthesis or guideline pooled it, 206 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Identification ofAntibiotics (Basel, Switzerland) · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Host-dependent effects ofFrontiers in microbiology · 2026
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

62 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 7 institutions in 5 countries.

Qiue YangDepartment of Medical Microbiology and Infectious Disease, Division of Infection and Immunity, Cardiff University, Cardiff, CF14 4XN, UK. YangQe@cardiff.ac.uk.
Mei LiDepartment of Medical Microbiology and Infectious Disease, Division of Infection and Immunity, Cardiff University, Cardiff, CF14 4XN, UK.
Owen B SpillerDepartment of Medical Microbiology and Infectious Disease, Division of Infection and Immunity, Cardiff University, Cardiff, CF14 4XN, UK.
Diego O AndreyDepartment of Medical Microbiology and Infectious Disease, Division of Infection and Immunity, Cardiff University, Cardiff, CF14 4XN, UK.ORCID http://orcid.org/0000-0003-3247-9274
Philip HinchliffeSchool of Cellular and Molecular Medicine, University of Bristol, Bristol, BS8 1TD, UK.
Hui LiBeijing Key Laboratory of Diagnostic and Traceability Technologies for Food Poisoning, Beijing Center for Disease Prevention and Control, Beijing, 100013, China.
Craig MacLeanDepartment of Zoology, University of Oxford, South Parks Road, Oxford, OX1 3PS, UK.ORCID http://orcid.org/0000-0002-7941-813X
Pannika NiumsupDepartment of Microbiology and Parasitology, Faculty of Medical Science, Naresuan University, Phitsanulok, 65000, Thailand.
Lydia PowellAdvanced Therapies Group, Oral and Biomedical Sciences, School of Dentistry, College of Biomedical and Life Sciences, Cardiff University, Heath Park, Cardiff, CF14 4XN, UK.
Manon PritchardAdvanced Therapies Group, Oral and Biomedical Sciences, School of Dentistry, College of Biomedical and Life Sciences, Cardiff University, Heath Park, Cardiff, CF14 4XN, UK.
Andrei PapkouDepartment of Zoology, University of Oxford, South Parks Road, Oxford, OX1 3PS, UK.
Yingbo ShenBeijing Advanced Innovation Centre for Food Nutrition and Human Health, College of Veterinary Medicine, China Agricultural University, Beijing, 100193, China.
Edward PortalDepartment of Medical Microbiology and Infectious Disease, Division of Infection and Immunity, Cardiff University, Cardiff, CF14 4XN, UK.
Kirsty SandsDepartment of Medical Microbiology and Infectious Disease, Division of Infection and Immunity, Cardiff University, Cardiff, CF14 4XN, UK.
James SpencerSchool of Cellular and Molecular Medicine, University of Bristol, Bristol, BS8 1TD, UK.
Uttapoln TansawaiDepartment of Microbiology and Parasitology, Faculty of Medical Science, Naresuan University, Phitsanulok, 65000, Thailand.
David ThomasAdvanced Therapies Group, Oral and Biomedical Sciences, School of Dentistry, College of Biomedical and Life Sciences, Cardiff University, Heath Park, Cardiff, CF14 4XN, UK.
Shaolin WangBeijing Advanced Innovation Centre for Food Nutrition and Human Health, College of Veterinary Medicine, China Agricultural University, Beijing, 100193, China.
Yang WangBeijing Advanced Innovation Centre for Food Nutrition and Human Health, College of Veterinary Medicine, China Agricultural University, Beijing, 100193, China.
Jianzhong ShenBeijing Advanced Innovation Centre for Food Nutrition and Human Health, College of Veterinary Medicine, China Agricultural University, Beijing, 100193, China.
Timothy WalshDepartment of Medical Microbiology and Infectious Disease, Division of Infection and Immunity, Cardiff University, Cardiff, CF14 4XN, UK. WalshTR@cardiff.ac.uk.
Cardiff University · GBChina Agricultural University · CNNaresuan University · THUniversity of Bristol · GBUniversity of Oxford · GBBeijing Center for Disease Prevention and Control · CNUniversity Hospital of Geneva · CH

Funding

Medical Research Council MR/N028317/1Medical Research Council MR/P007295/1
6 · The paper itself

Abstract

MCR-1 is a lipid A modifying enzyme that confers resistance to the antibiotic colistin. Here, we analyse the impact of MCR-1 expression on E. coli morphology, fitness, competitiveness, immune stimulation and virulence. Increased expression of mcr-1 results in decreased growth rate, cell viability, competitive ability and significant degradation in cell membrane and cytoplasmic structures, compared to expression of catalytically inactive MCR-1 (E246A) or MCR-1 soluble component. Lipopolysaccharide (LPS) extracted from mcr-1 strains induces lower production of IL-6 and TNF, when compared to control LPS. Compared to their parent strains, high-level colistin resistance mutants (HLCRMs) show reduced fitness (relative fitness is 0.41-0.78) and highly attenuated virulence in a Galleria mellonella infection model. Furthermore, HLCRMs are more susceptible to most antibiotics than their respective parent strains. Our results show that the bacterium is challenged to find a delicate equilibrium between expression of MCR-1-mediated colistin resistance and minimalizing toxicity and thus ensuring cell survival.

Indexed as

AnimalsAnti-Bacterial AgentsCell MembraneColistinDisease Models, AnimalDrug Resistance, BacterialEscherichia coliEscherichia coli InfectionsEscherichia coli ProteinsHumansLarvaMicrobial Sensitivity TestsMothsAnti-Bacterial AgentsColistinEscherichia coli ProteinsMCR-1 protein, E coli

Identifiers

PMID29233990
PMCPMC5727292
OpenAlexW2772875632

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.